Cardiomac India Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 19-12-2024
- Paid Up Capital ₹ 0.90 M
as on 19-12-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 6.41 Cr
as on 19-12-2024
- Satisfied Charges ₹ 1.36 Cr
as on 19-12-2024
- Revenue -59.89%
(FY 2022)
- Profit -103.99%
(FY 2022)
- Ebitda -59.37%
(FY 2022)
- Net Worth -0.40%
(FY 2022)
- Total Assets -1.97%
(FY 2022)
About Cardiomac India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹6.41 Cr. The company has closed loans amounting to ₹1.36 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rahul Yadav and Sunita Yadav serve as directors at the Company.
- CIN/LLPIN
U51909DL2015PTC278542
- Company No.
278542
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 2015
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Cardiomac India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Yadav  | Director | 04-Jun-2021 | Current |
| Sunita Yadav | Director | 04-Jun-2021 | Current |
Financial Performance of Cardiomac India.
Cardiomac India Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 59.89% decrease. The company also saw a substantial fall in profitability, with a 103.99% decrease in profit. The company's net worth dipped by a decrease of 0.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cardiomac India?
Unlock access to Cardiomac India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Angstrom Biotech Private LimitedActive 24 years 10 monthsRahul Yadav and Sunita Yadav are mutual person
Innovation Triggers Mgmt Private LimitedActive 13 years 4 monthsRahul Yadav and Sunita Yadav are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Jun 2024 | ₹2.65 Cr | Open |
State Bank Of India Creation Date: 21 Sep 2023 | ₹1.75 Cr | Open |
Others Creation Date: 22 Mar 2019 | ₹2.11 M | Open |
How Many Employees Work at Cardiomac India?
Cardiomac India has a workforce of 19 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cardiomac India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cardiomac India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
